Accessibility Menu
 
Shuttle Pharmaceuticals logo

Shuttle Pharmaceuticals

(NASDAQ) SHPH

Current Price$0.76
Market Cap$4.24M
Since IPO (2022)-100%
5 YearN/A
1 Year-93%
1 Month-15%

Shuttle Pharmaceuticals Financials at a Glance

Market Cap

$4.24M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.72M

EPS (TTM)

$-13.23

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.76

Volume

1,303

Open

$0.67

Previous Close

$0.76

Daily Range

$0.67 - $0.76

52-Week Range

$0.50 - $13.63

SHPH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shuttle Pharmaceuticals

Industry

Biotechnology

Employees

2

CEO

Christopher Robert Cooper, MBA

Headquarters

Gaithersburg, MD 20850, US

SHPH Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-791%

Return on Capital

-5%

Return on Assets

-1%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.24M

Shares Outstanding

5.59M

Volume

1.30K

Short Interest

0.00%

Avg. Volume

2.61M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.92M

EBITDA

$11.92M

Operating Cash Flow

$9.48M

Capital Expenditure

$0.00

Free Cash Flow

$9.48M

Cash & ST Invst.

$334.00K

Total Debt

$232.15K

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.01K

+156.1%

Gross Margin

0.00%

N/A

Market Cap

$4.24M

N/A

Market Cap/Employee

$471.53K

N/A

Employees

9

N/A

Net Income

$2.61M

-63.6%

EBITDA

$2.64M

-83.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$101.86K

-86.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$154.95K

-34.9%

Short Term Debt

$77.19K

-91.7%

Return on Assets

-1.12%

N/A

Return on Invested Capital

-4.75%

N/A

Free Cash Flow

$973.01K

+63.8%

Operating Cash Flow

$973.01K

+63.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HSCSHeartSciences Inc.
$2.30-2.54%
RDHLRedHill Biopharma Ltd.
$0.80-1.68%
BBLGBone Biologics Corporation
$1.24+6.90%
UPCUniverse Pharmaceuticals Inc.
$3.16+15.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
NVDANvidia
$177.39+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%

Questions About SHPH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.